valine has been researched along with Hyperplasia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, SA; Burns-Naas, LA; Denlinger, RH; Han, B; Hosea, NA; Liu, L; May, JR; Randolph, S; Scott, W | 1 |
| Sakaida, H; Sano, T; Suzuki, H; Taki, W; Toma, N; Umeda, Y; Yamamoto, A | 1 |
| Cai, S; Li, Y; Liu, X; Ren, B; Sun, T; Wang, Q; Xu, Q; Yu, H; Zhou, J | 1 |
| deBlois, D; Der Sarkissian, S; Duguay, D; Hamet, P; Marchand, EL | 1 |
| CARNEVALI, R; POLI, E; RAINERI, P | 1 |
| Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R | 1 |
| Chen, H; Ding, RJ; Jia, SQ; Li, GH; Li, HW; Wang, L; Yao, DK; Zhao, L | 1 |
| Guan, YY; Liu, YJ; Lu, HH; Sheng, ZQ; Wang, Y; Zhang, L | 1 |
| Dirnhofer, S; Hao-Shen, H; Looser, R; Schwaller, J; Skoda, RC; Sobas, MA; Tiedt, R | 1 |
| Scott, EB | 1 |
| Metcalfe, DD; Shah, PY; Sharma, V; Worobec, AS; Zwick, DC | 1 |
| Levine, GM; Pusateri, JP; Weinberg, LM | 1 |
| Arant, BS; Brackett, NC; Still, WJ; Young, RB | 1 |
| Goldwasser, E; Gross, M | 1 |
14 other study(ies) available for valine and Hyperplasia
| Article | Year |
|---|---|
Intermittent oral coadministration of a gamma secretase inhibitor with dexamethasone mitigates intestinal goblet cell hyperplasia in rats.
Topics: Administration, Oral; Amyloid Precursor Protein Secretases; Animals; Body Weight; Dexamethasone; Goblet Cells; Hyperplasia; Intestines; Male; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Valine | 2014 |
Valsartan prevents neointimal hyperplasia after carotid artery stenting by suppressing endothelial cell injuries.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Calcium Channel Blockers; Carotid Arteries; Carotid Stenosis; Endothelial Cells; Female; Humans; Hyperplasia; Hypertension; Male; Prospective Studies; Stents; Tetrazoles; Treatment Outcome; Ultrasonography; Valine; Valsartan | 2015 |
Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor.
Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Aorta, Thoracic; Bilirubin; DNA Primers; Gene Expression Regulation; Heme Oxygenase-1; Hyperplasia; Male; Neointima; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Valine; Valsartan | 2014 |
Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Enalapril; Fibroblasts; Heart Ventricles; Hyperplasia; Hypertension; Hypertrophy, Left Ventricular; In Situ Nick-End Labeling; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan | 2003 |
[HYPOGLYCEMIC REACTION TO LEUCINE, VALINE AND PHENYLALANINE IN A CASE OF DIFFUSE HYPERPLASIA OF THE BETA CELLS].
Topics: Glucose Tolerance Test; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Hypoglycemic Agents; Insulin-Secreting Cells; Islands; Islets of Langerhans; Leucine; Pathology; Pharmacology; Phenylalanine; Tolbutamide; Valine | 1963 |
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis | 2004 |
[Valsartan eluting-stents inhibited neointimal hyperplasia by decreasing collagen deposition in rabbits].
Topics: Animals; Collagen; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Hyperplasia; Male; Rabbits; Tetrazoles; Tunica Intima; Valine; Valsartan | 2006 |
[Effect of valsartan on neointimal proliferation and expression of vWF after balloon angioplasty in rabbits].
Topics: Angioplasty, Balloon; Animals; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Hyperplasia; Male; Postoperative Period; Rabbits; Random Allocation; Tetrazoles; Tunica Intima; Valine; Valsartan; von Willebrand Factor | 2007 |
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
Topics: Animals; Colony-Forming Units Assay; Granulocytes; Hematopoiesis, Extramedullary; Humans; Hyperplasia; Integrases; Janus Kinase 2; Megakaryocytes; Mice; Mice, Transgenic; Mutant Proteins; Myeloproliferative Disorders; Phenotype; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis; Recombination, Genetic; Thrombocythemia, Essential; Transgenes; Valine | 2008 |
Nodular hyperplasia in thyroids of aged rats fed normal or valine-deficient diets.
Topics: Age Factors; Animals; Deficiency Diseases; Hyperplasia; Rats; Thyroid Diseases; Valine | 1967 |
Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation.
Topics: Aspartic Acid; Bone Marrow; Fatal Outcome; Granulocytes; Humans; Hyperplasia; Infant, Newborn; Leukocytosis; Male; Mast Cells; Myeloproliferative Disorders; Point Mutation; Proto-Oncogene Proteins c-kit; Urticaria Pigmentosa; Valine | 1998 |
Comparison of different caloric substrates on intestinal adaptation in the rat.
Topics: Adaptation, Physiological; Animals; Aspartic Acid; Dietary Carbohydrates; Dietary Fats; Emulsions; Fat Emulsions, Intravenous; Glucose; Hyperplasia; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Phospholipids; Rats; Rats, Inbred Strains; Soybean Oil; Triglycerides; Valine | 1989 |
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Male; Spironolactone; Triamterene; Valine | 1970 |
On the mechanism of erythropoietin-induced differentiation. IX. Induced synthesis of 9 S ribonucleic acid and of hemoglobin.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Carbon Isotopes; Cell Differentiation; Centrifugation, Density Gradient; Culture Techniques; Erythropoietin; Female; Glycine; Hemoglobins; Hyperplasia; Iron Isotopes; Male; Mice; Polycythemia; Rats; RNA; RNA, Messenger; Time Factors; Valine | 1971 |